Efficacy of disopyramide in conversion a
โ
H. Nakazawa; N. Ishikawa; J. Noh; T. Sugimoto; M. Yoshimoto; T. Yashiro; O. Ozak
๐
Article
๐
1991
๐
Springer
๐
English
โ 461 KB
Rhythm conversion in patients with post-thyrotoxic atrial fibrillation (AF) has been performed with disopyramide in order to evaluate the conversion rate and to test its effect on the maintenance of sinus rhythm after cardioversion. The duration of AF ranged from 9 to 122 months (mean 31.8 months).